WallStreetZenWallStreetZen

NASDAQ: ETON
Eton Pharmaceuticals Inc Stock Ownership - Who owns Eton Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Eton Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Norbert G. RiedelDirector2026-02-0330,000$4.42
$132.60kBuy
David KrempaChief Business Officer2026-01-141,942$15.62
$30.33kSell
James R. GruberChief Financial Officer2026-01-142,293$15.47
$35.47kSell
Sean BrynjelsenPresident CEO2026-01-015,015$15.39
$77.18kSell
James R. GruberChief Financial Officer2025-12-124,542$16.99
$77.17kSell
Sean BrynjelsenPresident CEO2025-12-126,732$16.83
$113.30kSell
Ipek ErdogantrinkausChief Commercial Officer2025-12-1285$16.90
$1.44kSell
David KrempaChief Business Officer2025-12-126,264$17.00
$106.49kSell
James R. GruberChief Financial Officer2025-08-202,631$16.02
$42.15kSell
James R. GruberChief Financial Officer2025-08-1939,082$16.16
$631.57kSell

1 of 2

ETON insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ETON insiders and whales buy or sell their stock.

ETON Shareholders

What type of owners hold Eton Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Opaleye Management Inc10.95%2,937,070$55.86MInsider
Sean Brynjelsen10.87%2,914,206$55.43MInsider
Opaleye Management Inc10.66%2,860,000$54.40MInstitution
Ecor1 Capital LLC7.57%2,030,544$38.62MInstitution
Harrow Health Inc7.39%1,982,000$37.70MInsider
Blackrock Inc6.48%1,738,907$33.07MInstitution
Vanguard Group Inc5.03%1,348,668$25.65MInstitution
Nantahala Capital Management LLC4.39%1,175,951$22.37MInstitution
David Krempa2.35%630,238$11.99MInsider
Geode Capital Management LLC2.11%565,051$10.75MInstitution

1 of 3

ETON vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ETON58.24%32.85%Net SellingNet Buying
IRWD72.40%27.60%Net SellingNet Selling
KMDA9.32%7.19%
AQST59.15%6.65%Net SellingNet Selling
ESPR58.90%16.57%Net SellingNet Selling
View Top Pharmaceutical Stocks

Eton Pharmaceuticals Stock Ownership FAQ

Who owns Eton Pharmaceuticals?

Eton Pharmaceuticals (NASDAQ: ETON) is owned by 58.24% institutional shareholders, 32.85% Eton Pharmaceuticals insiders, and 8.91% retail investors. Opaleye Management Inc is the largest individual Eton Pharmaceuticals shareholder, owning 2.94M shares representing 10.76% of the company. Opaleye Management Inc's Eton Pharmaceuticals shares are currently valued at $61.00M.

If you're new to stock investing, here's how to buy Eton Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.